P. Mesters

763 total citations
19 papers, 578 citations indexed

About

P. Mesters is a scholar working on Pharmacology, Psychiatry and Mental health and Social Psychology. According to data from OpenAlex, P. Mesters has authored 19 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 4 papers in Social Psychology. Recurrent topics in P. Mesters's work include Treatment of Major Depression (10 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Health, Medicine and Society (3 papers). P. Mesters is often cited by papers focused on Treatment of Major Depression (10 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Health, Medicine and Society (3 papers). P. Mesters collaborates with scholars based in Belgium, France and United States. P. Mesters's co-authors include Koen Demyttenaere, Paul Enzlin, Bruno Boulanger, Jacques Grégoire, Éric Van Ganse, Walthère Dewé, Adelin Albert, P. Saltel, Darius Razavi and D. Sechter and has published in prestigious journals such as Biological Psychiatry, Journal of Affective Disorders and Clinical Pharmacology & Therapeutics.

In The Last Decade

P. Mesters

19 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Mesters Belgium 11 252 238 136 128 89 19 578
R. Tepner United States 10 324 1.3× 354 1.5× 272 2.0× 86 0.7× 86 1.0× 19 801
M. Bouhassira France 13 262 1.0× 148 0.6× 89 0.7× 60 0.5× 84 0.9× 25 532
Herbert Pfeiffer Germany 20 659 2.6× 128 0.5× 129 0.9× 123 1.0× 48 0.5× 33 969
R.C. Peveler United Kingdom 3 207 0.8× 262 1.1× 118 0.9× 120 0.9× 9 0.1× 5 590
Maria Teresa Peñarrubia‐María Spain 17 381 1.5× 304 1.3× 55 0.4× 98 0.8× 7 0.1× 45 736
Melina Siamouli Greece 17 360 1.4× 94 0.4× 94 0.7× 76 0.6× 11 0.1× 38 768
Enrico Capuzzi Italy 14 280 1.1× 84 0.4× 68 0.5× 62 0.5× 33 0.4× 63 704
N Rudas Italy 16 354 1.4× 96 0.4× 78 0.6× 114 0.9× 41 0.5× 28 626
Judith Strobl United Kingdom 8 132 0.5× 95 0.4× 143 1.1× 49 0.4× 8 0.1× 11 501
Guy Sapirstein United States 7 164 0.7× 203 0.9× 134 1.0× 71 0.6× 14 0.2× 9 873

Countries citing papers authored by P. Mesters

Since Specialization
Citations

This map shows the geographic impact of P. Mesters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Mesters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Mesters more than expected).

Fields of papers citing papers by P. Mesters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Mesters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Mesters. The network helps show where P. Mesters may publish in the future.

Co-authorship network of co-authors of P. Mesters

This figure shows the co-authorship network connecting the top 25 collaborators of P. Mesters. A scholar is included among the top collaborators of P. Mesters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Mesters. P. Mesters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mesters, P., et al.. (2017). [Professional fatigue syndrome (burnout). Part 1 : identification by the general practitioner].. PubMed. 72(5). 246–252. 2 indexed citations
2.
Mesters, P., et al.. (2017). [Professional fatigue syndrome (burnout) : Part 2 : from therapeutic management].. PubMed. 72(6). 301–307. 6 indexed citations
3.
Mesters, P., et al.. (2008). Le burn out, comprendre et vaincre l'épuisement professionnel. 1 indexed citations
4.
Demyttenaere, Koen, et al.. (2005). What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors?. The Journal of Clinical Psychiatry. 66(7). 859–863. 24 indexed citations
5.
Demyttenaere, Koen, et al.. (2004). Development of an antidepressant compliance questionnaire. Acta Psychiatrica Scandinavica. 110(3). 201–207. 37 indexed citations
6.
Demyttenaere, Koen, et al.. (2002). Six month compliance with fluoxetine or paroxetine treatment in depressed outpatients. European Neuropsychopharmacology. 12. 208–208. 3 indexed citations
7.
Demyttenaere, Koen, et al.. (2001). Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events.. PubMed. 62 Suppl 22. 30–3. 172 indexed citations
8.
Demyttenaere, Koen, et al.. (2001). Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.. PubMed. 62 Suppl 22. 34–7. 45 indexed citations
9.
Girard, Pierre‐Marie, et al.. (1999). Compliance and drop-out model for once a day regimen in depressed patients. Clinical Pharmacology & Therapeutics. 65(2). 172–172. 3 indexed citations
10.
Ganse, Éric Van, et al.. (1998). Compliance in depressed patients treated with fluoxetine or amitriptyline. International Clinical Psychopharmacology. 13(1). 11–18. 61 indexed citations
11.
Demyttenaere, Koen, Éric Van Ganse, Philippe Grégoire, & P. Mesters. (1997). Compliance among patients suffering from major depressive disorder and treated by fluoxetine or amitriptyline. Biological Psychiatry. 42(1). 240S–240S. 1 indexed citations
12.
Razavi, Darius, J.‐F. Allilaire, Mark A. Smith, et al.. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica. 94(3). 205–210. 128 indexed citations
13.
14.
Grégoire, Jacques, et al.. (1994). Validation of the quality of life in depression scale in a population of adult depressive patients aged 60 and above. Quality of Life Research. 3(1). 13–19. 20 indexed citations
15.
Mesters, P., Paul Cosyns, Christian Gilles, et al.. (1993). Assessment of quality of life in the treatment of major depressive disorder with fluoxetine, 20 mg, in ambulatory patients aged over 60 years. International Clinical Psychopharmacology. 8(4). 337–340. 17 indexed citations
16.
Gilles, Christian, et al.. (1990). Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium. Acta Psychiatrica Scandinavica. 82(S360). 42–42. 14 indexed citations
17.
Hubain, Philippe, P Castro, P. Mesters, Viviane De Maertelaer, & Julien Mendlewicz. (1990). Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study. Journal of Affective Disorders. 18(1). 67–73. 12 indexed citations
18.
Charles, G, et al.. (1989). [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].. PubMed. 88(2). 153–61. 1 indexed citations
19.
Charles, G, et al.. (1988). Growth hormone response to clonidine in panic disorder patients. Psychiatry Research. 23(2). 147–151. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Tepner Breakdown of academic impact, for papers by M. Bouhassira Breakdown of academic impact, for papers by Herbert Pfeiffer Breakdown of academic impact, for papers by R.C. Peveler Breakdown of academic impact, for papers by Maria Teresa Peñarrubia‐María Breakdown of academic impact, for papers by Melina Siamouli Breakdown of academic impact, for papers by Enrico Capuzzi Breakdown of academic impact, for papers by N Rudas Breakdown of academic impact, for papers by Judith Strobl Breakdown of academic impact, for papers by Guy Sapirstein
Rankless by CCL
2026